Skip to main content

Table 3 Characteristics of the study population by metabolic phenotype among underweight and normal weight individuals

From: Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study

Characteristics

Underweight (BMIa <18.50 kg/m2)

Normal weight (BMIa 18.50–24.99 kg/m2)

p-value*

n = 7,747

n = 202,265

Healthy

Unhealthy

Healthy

Unhealthy

Healthy

Unhealthy

n = 7,711

n = 36

n = 197,846

n = 4,419

  

Prevalence, %

1.7

0.0

43.8

1.0

  

(95 % CI)b

(1.7–1.7)

(0.0–0.0)

(43.7–44)

(1.0–1.0)

  

Age (years), mean [SD]c (95 % CI)b

28.4 [8.3]

38.6 [12.4]

32.8 [9.7]

41.8 [11.4]

<0.0001

0.0988

(28.2–28.6)

(34.4–42.8)

(32.7–32.8)

(41.4–42.1)

Female, %

66.2

16.7

40.7

16.2

<0.0001

0.9403

(95 % CI)b

(65.2–67.3)

(7.9–31.9)

(40.4–40.9)

(15.1–17.3)

Blue-collar worker, %

54.7

66.7

60.4

72.8

<0.0001

0.4176

(95 % CI)b

(53.5–55.8)

(50.3–79.8)

(60.2–60.7)

(71.5–74.1)

Smoking status, % (95 % CI)b

      

Never smoker

37.6

11.1

39.3

26.3

<0.0001

0.0570

(36.5–38.7)

(4.4–25.3)

(39.1–39.6)

(25–27.6)

Former smoker (stopped smoking ≥1 year ago)

5.6

16.7

9.4

13.6

(5.1–6.1)

(7.9–31.9)

(9.3–9.6)

(12.6–14.6)

Former smoker (stopped smoking <1 year ago)

2.4

0.0

2.7

2.8

(2.1–2.8)

(0.0–9.6)

(2.6–2.7)

(2.4–3.3)

Current smoker

54.5

72.2

48.6

57.4

(53.4–55.6)

(56.0–84.2)

(48.3–48.8)

(55.9–58.8)

Heavy drinker, %

1.3

2.8

1.8

3.5

0.0001

0.8113

(95 % CI)b

(1.0–1.5)

(0.5–14.2)

(1.8–1.9)

(3.0–4.1)

Physical exercised, % (95 % CI)b

      

Regular physical exercise

16.6

0.0

23.1

16.2

<0.0001

0.5628

(15.1–18.2)

(0.0–43.4)

(22.7–23.5)

(13.6–19.2)

≥2 h/week of physical exercise

9.1

20.0

9.7

10.9

(8.0–10.4)

(3.6–62.4)

(9.5–10.0)

(8.7–13.4)

<2 h/week physical exercise

11.9

20.0

16.0

13.7

(10.6–13.4)

(3.6–62.4)

(15.7–16.4)

(11.3–16.5)

No physical exercise

62.3

60.0

51.1

59.2

(60.3–64.4)

(23.1–88.2)

(50.7–51.6)

(55.5–62.9)

Systolic blood pressure (mmHg), mean [SD]c (95 % CI)b

112.5 [13.5]

136.7 [14.9]

119.8 [14.5]

138.1 [15.3]

<0.0001

0.5729

(112.2–112.8)

(131.6–141.7)

(119.8–119.9)

(137.6–138.5)

Diastolic blood pressure (mmHg), mean [SD]c (95 % CI)b

69.4 [9.3]

83.3 [11.2]

72.2 [9.5]

82.3 [10.3]

<0.0001

0.5457

(69.2–69.6)

(79.5–87.1)

(72.2–72.3)

(82.0–82.6)

Hypertension, %

12.9

86.1

26.2

90.7

<0.0001

0.3732

(95 % CI)b

(12.2–13.7)

(71.3–93.9)

(26.0–26.4)

(89.8–91.5)

HDL cholesterol (mg/dL), mean [SD]c (95 % CI)b

60.4 [14.7]

43.4 [14.4]

56.5 [13.9]

43.5 [12.4]

<0.0001

0.9765

(60.1–60.8)

(38.6–48.3)

(56.5–56.6)

(43.1–43.9)

Triglycerides (mg/dL), mean [SD]c (95 % CI)b

68.5 [31.1]

226.4 [246.2]

82.5 [50.2]

209.2 [133.7]

<0.0001

0.6787

(67.8–69.2)

(143.1–309.7)

(82.3–82.7)

(205.3–213.2)

Hypertriglyceridemia, %

2.4

75.0

7.0

83.1

<0.0001

0.2215

(95 % CI)b

(2.1–2.8)

(58.9–86.2)

(6.9–7.2)

(82.0–84.2)

Total cholesterol (mg/dL), mean [SD]c (95 % CI)b

172.3 [33.7]

194.7 [51.4]

185.6 [37.4]

209.8 [45.5]

<0.0001

0.0480

(171.6–173.1)

(177.3–212.1)

(185.4–185.8)

(208.4–211.1)

Hypercholesterolemia, %

19.8

47.2

33.1

61.0

<0.0001

0.0965

(95 % CI)b

(18.9–20.7)

(32.0–63.0)

(32.9–33.3)

(59.5–62.4)

Glucose level (mg/dL), mean [SD]c (95 % CI)b

82.6 [12.5]

105.4 [38.5]

85.6 [13.9]

108.3 [38.7]

<0.0001

0.6625

(82.3–82.9)

(92.4–118.4)

(85.5–85.6)

(107.1–109.4)

BMI (kg/m2), mean [SD]c (95 % CI)b

17.7 [0.7]

16.8 [1.6]

22.4 [1.7]

23.5 [1.3]

<0.0001

<0.0001

(17.7–17.7)

(16.3–17.3)

(22.4–22.4)

(23.4–23.5)

Waist circumference (cm), mean [SD]c (95 % CI)b

67.9 [6.4]

84.4 [17.5]

78.6 [8.1]

86.8 [8.3]

<0.0001

0.4090

(67.7–68.0)

(78.4–90.3)

(78.6–78.6)

(86.6–87.1)

  1. * P-values correspond to chi-squared test for categorical data, and t-test for continuous variables
  2. aBMI: body mass index
  3. b95% CI: 95 % confidence interval
  4. cSD: standard deviation
  5. dInformation on physical exercise was only available for a total of 100,561 study participants